Group Van Deurzen

Our main research subjects are:

• Subtype-specific characteristics of ductal carcinoma in situ of the breast, aiming to optimize treatment decisions
• Triple negative breast cancer: predictors of treatment response and seeking for treatment targets for those patients with poor response to neoadjuvant chemotherapy 
• HER2-low breast cancer: optimizing diagnostics to select patients with potential benefit from novel therapies.  

2013-2017: Fellowship Erasmus MC

2015: Male breast cancer characteristics, Breast Cancer Research Foundation (BCRF)

2016: Micro-environment across subtypes of ductal carcinoma in situ of the breast,

Roche

2018: Role of tumor infiltrating lymfocytes during breast carcinogenesis, Aspasia,

ZonMw

2021: Seeking for treatment targets for TNBC patients with poor response on

neoadjuvant treatment, Roche

2021: HER2-low breast cancer, Astrazeneca

Nadine van den Ende, PhD student

Ximena Baez Navarro, PhD student

• 

  C.H.M. (Carolien) van Deurzen, Associate Professor

  Principal Investigator